Journal article
Civil society: A critical new advocate for vaccination in Europe
The vaccinology landscape has changed, with national authorities now being increasingly accountable to new stakeholders such as health insurers, regional regulatory bodies, the media, and civil society. Here, we discuss how civil society organisations (CSOs), such as patient and women\'s groups, have become important drivers in the introduction and sustainability of new vaccination programs. This shift in public implication in vaccine policy has been well illustrated in the recent introduction of human papillomavirus (HPV) vaccination in Europe. Patient and women\'s groups which were traditionally focused on advocacy of treatments have also become advocates for prevention with the advent of HPV vaccination.
Languages
- English
Publication year
2011
Journal
Vaccine
Volume
29
Issue
4
Type
Categories
Diseases
Countries
WHO Regions
